Literature DB >> 34837627

Multiple microRNA signature panel as promising potential for diagnosis and prognosis of head and neck cancer.

Sethu Thakachy Subha1, Yoke Kqueen Cheah2, Jun Wei Chin2, Norhafizah Mohtarrudin3, Hasni Idayu Saidi2.   

Abstract

MicroRNAs are small non-coding RNA that regulate gene expressions of human body. To date, numerous studies have reported that microRNAs possess great diagnostic and prognostic power in head and neck cancer and had governed a lot of attention. The factor for the successfulness of miRNAs in these aspects is due to cancer being fundamentally tied to genetic changes, which are regulated by these miRNAs. Head and neck cancer, leading the world record for cancer as number sixth, is caused by multiple risk factors such as tobacco consumption, alcohol consumption, dietary factors, ethnicity, family history, and human papilloma virus. It derives at locations such as oral cavity, pharynx, larynx, paranasal sinus and salivary gland and have high rate of mortality with high recurrence rate. Besides, head and neck cancer is also usually having poor prognosis due to its asymptomatic nature. However, this diagnostic and prognostic power can be further improved by using multiple panels of miRNA as a signature or even combined with TNM staging system to obtain even more remarkable results. This is due to multiple factors such as tumour heterogeneity and components of the tumour which may affect the composition of miRNAs. This review covers the examples of such miRNA signatures, compare their diagnostic and prognostic powers, discuss some controversial roles of unreported miRNAs, and the molecular mechanisms of the miRNAs in gene targeting and pathways.
© 2021. The Author(s), under exclusive licence to Springer Nature B.V.

Entities:  

Keywords:  Biomarker; Diagnosis; Head and neck squamous cell carcinoma (HNSCC); Prognosis; miRNA

Mesh:

Substances:

Year:  2021        PMID: 34837627     DOI: 10.1007/s11033-021-06954-1

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  52 in total

1.  Salivary exosomal miR-24-3p serves as a potential detective biomarker for oral squamous cell carcinoma screening.

Authors:  Lihong He; Fan Ping; Zhaona Fan; Chi Zhang; Miao Deng; Bin Cheng; Juan Xia
Journal:  Biomed Pharmacother       Date:  2019-11-05       Impact factor: 6.529

2.  Spatiotemporal regulation of epithelial-mesenchymal transition is essential for squamous cell carcinoma metastasis.

Authors:  Jeff H Tsai; Joana Liu Donaher; Danielle A Murphy; Sandra Chau; Jing Yang
Journal:  Cancer Cell       Date:  2012-11-29       Impact factor: 31.743

3.  Differential expression of microRNAs in plasma of patients with laryngeal squamous cell carcinoma: potential early-detection markers for laryngeal squamous cell carcinoma.

Authors:  Lokman Ayaz; Aysegül Görür; Hatice Yıldırım Yaroğlu; Cengiz Ozcan; Lülüfer Tamer
Journal:  J Cancer Res Clin Oncol       Date:  2013-07-02       Impact factor: 4.553

4.  The shaping and functional consequences of the microRNA landscape in breast cancer.

Authors:  Heidi Dvinge; Anna Git; Stefan Gräf; Mali Salmon-Divon; Christina Curtis; Andrea Sottoriva; Yongjun Zhao; Martin Hirst; Javier Armisen; Eric A Miska; Suet-Feung Chin; Elena Provenzano; Gulisa Turashvili; Andrew Green; Ian Ellis; Sam Aparicio; Carlos Caldas
Journal:  Nature       Date:  2013-05-05       Impact factor: 49.962

5.  Prognostic microRNA signatures derived from The Cancer Genome Atlas for head and neck squamous cell carcinomas.

Authors:  Nathan Wong; Shariq S Khwaja; Callie M Baker; Hiram A Gay; Wade L Thorstad; Mackenzie D Daly; James S Lewis; Xiaowei Wang
Journal:  Cancer Med       Date:  2016-04-25       Impact factor: 4.452

6.  A miRNA signature suggestive of nodal metastases from laryngeal carcinoma.

Authors:  F Ricciardiello; R Capasso; H Kawasaki; T Abate; F Oliva; A Lombardi; G Misso; D Ingrosso; C A Leone; M Iengo; M Caraglia
Journal:  Acta Otorhinolaryngol Ital       Date:  2017-12       Impact factor: 2.124

7.  Expression and clinical significance of miRNA-145 and miRNA-218 in laryngeal cancer.

Authors:  Libing Guo; Xiuyu Cai; Weihan Hu; Wenfeng Hua; Wen Yan; Yucheng Lin; Shengsong Yin; Yue Chen
Journal:  Oncol Lett       Date:  2019-05-13       Impact factor: 2.967

Review 8.  The Interplay between MicroRNAs and Cellular Components of Tumour Microenvironment (TME) on Non-Small-Cell Lung Cancer (NSCLC) Progression.

Authors:  Sook Shien Lee; Yoke Kqueen Cheah
Journal:  J Immunol Res       Date:  2019-02-13       Impact factor: 4.818

9.  A 3-miRNA signature predicts survival of patients with hypopharyngeal squamous cell carcinoma after post-operative radiotherapy.

Authors:  Xinbo Xu; Zhongming Lu; Neil Gross; Guojun Li; Fenghua Zhang; Dapeng Lei; Xinliang Pan
Journal:  J Cell Mol Med       Date:  2019-10-02       Impact factor: 5.310

10.  A radiosensitivity MiRNA signature validated by the TCGA database for head and neck squamous cell carcinomas.

Authors:  Ning Liu; Rebecca J Boohaker; Chunling Jiang; James R Boohaker; Bo Xu
Journal:  Oncotarget       Date:  2015-10-27
View more
  1 in total

1.  Differential Retrospective Analysis in Oral Cancerous, Pre-cancerous, and Benign Tissue Biopsies.

Authors:  Lampros Goutzanis
Journal:  Cureus       Date:  2022-05-13
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.